- 基本信息
|
导师姓名：
|
邱伟华
|
学科代码：
|
100210
|
|
|
性别：
|
男
|
学科名称：
|
外科学
|
|
培养单位：
|
附属瑞金医院
|
三级学科
|
普外
|
|
导师类型：
|
博士生导师
|
专业领域名称：
|
外科学 专业学位
|
|
联系方式：
|
drqwh2003@126.com/ qwh11072@rjh.com.cn
|
专业领域代码：
|
105111
|
|
邮编：
|
200025
|
邮箱地址：
|
Drqwh2003@126.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
| |
|
国家自然科学基金一审专家
|
|
美国外籍医师教育委员会（ECFMG）注册医师
|
|
中华医学会外科学分会实验外科与转化医学学组
|
|
美国外科研究协会（ASR）会员
|
|
欧洲肿瘤研究协会（EACR）会员
|
|
上海市医学会普外科专委会甲状腺外科学组
|
|
《中华实验外科杂志》、《世界胃肠病学》、《外科理论与实践》杂志编委
|
|
上海市医学会普外科专委会甲状腺外科学组
|
|
美国医师执照考试委员会（USMLE）注册医师
|
|
教育部回国留学科研启动基金评审专家
|
|
上海市青年联合会会员
|
|
美国肿瘤研究协会（AACR）会员
|
- 科研项目
| 82003169 | FOXK2-VEGFA信号轴介导甲状腺未分化癌阿帕替尼靶向治疗敏感性及其机制研究 | 国家自然科学基金青年项目 |
2021-01~2023-12
|
24万元
| 课题参与人 |
| 82072948 | LncRNA-CTSLL4—FOXK2功能轴对甲状腺未分化癌生物学特性和靶向治疗敏感性影响及其调控机制研究 | 国家自然科学基金面上项目 |
2021-01~2024-12
|
55万元
| 课题负责人 |
| Y-HR2017-026 | 甲磺酸阿帕替尼治疗晚期甲状腺癌患者的有效性和安全性临床研究 | 北京市CSCO临床肿瘤学研究基金会 |
2018-10~2021-10
|
5万元
| 课题负责人 |
| 81772558 | FGFR3/TET2/p-TET2轴异常激活对肝癌生物学特性影响及调控机制 | 国家自然科学基金面上项目 |
2018-01~2021-12
|
58万元
| 课题负责人 |
| / | FGFR3Δ7-9对肝癌TET2(Y1902F)蛋白磷酸化的差异调控作用研究 | 上海市科委慈善癌症研究基金 |
2016-01~2019-12
|
5万元
| 课题负责人 |
| / | 调节性T细胞对胰腺癌免疫微环境和肿瘤生物学行为的调控作用研究 | 上海市科委慈善癌症研究基金 |
2013-01~2016-12
|
5万元
| 课题负责人 |
| 81172326 | 肝癌细胞中FGFR3特异性剪接变异的功能效应及其调控研究 | 国家自然科学基金面上项目 |
2012-01~2015-12
|
59万元
| 课题负责人 |
| 30872511 | GADD45β表达诱导对肝癌细胞II型程序性细胞死亡（自吞噬）的调控及其作用机制 | 国家自然基金委,面上项目 |
2009-01~2011-12
|
35万元
| 课题负责人 |
| 08QA1404700 | GADD45β表达诱导对肝癌细胞II型程序性细胞死亡（自吞噬）的调控及其作用机制 | 上海市科委,启明星 |
2008-07~2010-07
|
15万元
| 课题负责人 |
| 30500493 | 肝癌细胞特异性表达缺失基因GADD45β的分子调控机制及其意义研究 | 国家自然基金委,面上项目 |
2006-01~2008-12
|
25万元
| 课题负责人 |
| 04BC32 | GADD45β在肝癌中表达调控的基础和临床研究 | 上海市教委,青年基金 |
2005-01~2007-12
|
2万元
| 课题负责人 |
- 学术论文
|
Zhao Q, Feng H, Yang Z, Liang J, Jin Z, Chen L, Zhan L, Xuan M, Yan J, Kuang J, Cheng X, Zhao R,
|
The central role of a two-way positive feedback pathway in molecular targeted therapies-mediated pyroptosis in anaplastic thyroid cancer.
|
Clinical and Translational Medicine
|
2022
|
Feb;12(2):e727.
|
|
Heng Y, Feng S, Yang Z, Cai W,, Tao L
|
Features of Lymph Node Metastasis and Structural Recurrence in Papillary Thyroid Carcinoma Located in the Upper Portion of the Thyroid: A Retrospective Cohort Study.
|
Front Endocrinol
|
2022
|
Jan 25;12:793997.
|
|
Kuang J, Jin Z, Chen L, Zhao Q, Huang H, Liu Z, Yang W, Feng H, Yang Z, Díez JJ, Pusztaszeri M, Kim JM, Bonati E, Cheng X, Yan J, Qiu W.
|
Serum 25-hydroxyvitamin D level is unreliable as a risk factor and prognostic marker in papillary thyroid cancer.
|
Ann Transl Med
|
2022
|
Feb;10(4):193.
|
|
Liang J, Jin Z, Kuang J, Feng H, Zhao Q, Yang Z, Zhan L, Shen B, Yan J, Cai W, Cheng X,
|
The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis
|
British Journal of Cancer
|
2021
|
125(3):390-401
|
|
Feng H, Jin Z, Liang J, Zhao Q, Zhan L, Yang Z, Yan J, Kuang J, Cheng X,
|
FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway.
|
Oncogene
|
2021
|
Oct;40(42):6115-6129.
|
|
Yang Z, Heng Y, Zhao Q, Cao Z, Tao L,, Cai W.
|
A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.
|
Front Endocrinol
|
2021
|
Sep 30;12:743900.
|
|
Liang J, Zhan L, Xuan M, Zhao Q, Chen L, Yan J, Kuang J, Tan J,
|
Thyroidectomy for thyroid cancer via transareola single-site endoscopic approach: results of a case-match study with large-scale population
|
Surgical Endoscopy
|
2021
|
Mar 29
|
|
Sun H, Liu Z, Gao H, Kuang J, Chen X, Li Q, Di Z,, Yan J.
|
Predictive factors for prolonged operative time of robotic thyroidectomy via bilateral axillo-breast approach: Analysis of 359 cases of differentiated thyroid cancer
|
Asian J Surgery
|
2021
|
S1015-9584(21)00179-2
|
|
Jin Z, Lu Y, Wu X, Pan T, Yu Z, Hou J, Wu A, Li J, Yang Z, Li C, Yan M, Yan C, Zhu Z, Liu B,, Su L.
|
The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer
|
Redox Biology
|
2021
|
Jul 20;46:102076
|
|
Jin Z, Feng H, Liang J, Jing X, Zhao Q, Zhan L, Shen B, Cheng X, Su L,
|
FGFR3 △7-9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma
|
Cell Death Dis
|
2020
|
Oct 23;11(10):903.
|
|
Feng H, Jin Z, Liu K, Peng Y, Jiang S, Wang C, Hu J, Shen X,, Cheng X, Zhao R.
|
Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
|
J Cell Mol Med
|
2020
|
Nov;24(21):12667-12680.
|
|
Shi Y, Jin J,, Weng Y, Wang J, Zhao S, Huo Z, Qin K, Wang Y, Chen H, Deng X, Peng C, Shen B.
|
Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve
|
JAMA Surgery
|
2020
|
May 1;155(5):389-394.
|
|
Feng H, Liu K, Shen X, Liang J, Wang C,, Cheng X, Zhao R.
|
Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5 + colorectal cancer
|
Cell Death Dis
|
2020
|
Oct 24;11(10):916.
|
|
Jing X, Wang XJ, Zhang T, Zhu W, Fang Y, Wu H, Liu X, Ma D, Ji X, Jiang Y, Liu K, Chen X, Shi Y, Zhang Y, Shi M,, Zhao R.
|
Cell cycle-dependent phosphorylation of PRPS1 fuels nucleotide synthesis and promotes tumorigenesis.
|
Cancer Research
|
2019
|
2019 Jun 28. pii: canres.2486.2018.
|
|
Cheng X, Jin Z, Ji X, Shen X, Feng H, Morgenlander W, Ou B, Wu H, Gao H, Ye F, Zhang Y, Peng Y, Liang J, Jiang Y, Zhang T,, Lu X, Zhao R.
|
ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB
|
International Journal of Cancer
|
2019
|
Jan 16. doi: 10.1002/ijc.32071
|
|
Shi Y, Wang W,, Zhao S, Wang J, Weng Y, Huo Z, Jin J, Wang Y, Deng X, Shen B, Peng C.
|
Learning Curve From 450 Cases of Robot-Assisted Pancreaticoduocectomy in a High-Volume Pancreatic Center: Optimization of Operative Procedure and a Retrospective Study.
|
Annals of Surgery
|
2019
|
2019 Oct 22. doi: 10.1097/SLA.0000000000003664
|
|
Feng H, Cheng X, Kuang J, Chen L, Yuen S, Shi M, Liang J, Shen B, Jin Z, Yan J,
|
Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer
|
Cell Death Dis
|
2018
|
9(10):1030.
|
|
Fu Z, Cheng X, Kuang J, Feng H, Chen L, Liang J, Shen X, Yuen S, Peng C, Shen B, Jin Z,
|
CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species.
|
Molecular Oncology
|
2018
|
12(4):529-544
|
|
Xi Cheng, Haoran Feng, Haoxuan Wu, Zhijian Jin, Xiaonan Shen, Zhen Huo, Xianze Chen, Haoji Gao, Feng Ye, Xiaopin Ji, Xiaoqian Jing, Yaqi Zhang, Tao Zhang,, Ren Zhao.
|
Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer
|
Cancer Letters
|
2018
|
431(18):105-114
|
|
Cheng X, Feng H, Chen L, Jin Z, Shao T, Wang Y, Liang J, Sun H, Yang W, Zhao R, Shen B, Kuang J, Yan J,
|
Intraoperative carbon nanoparticles mapping in secondary total thyroidectomy for recurrent thyroid nodules: Results of a 8-criterion case-match study
|
International Journal of Surgery
|
2018
|
60(18):210-215
|
|
Jin Z, Cheng X, Feng H, Kuang J, Yang W, Peng C, Shen B,
|
Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer
|
Cell Physiol Biochem
|
2017
|
1;44(4):1471-1484.
|
|
Cheng X, Wu H, Jin ZJ, Ma D, Yuen S, Jing XQ, Shi MM, Shen BY, Peng CH, Zhao R,
|
Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior.
|
Scientific Reports
|
2017
|
7(1):12362.
|
|
Deng X, Cheng X, Huo Z, Shi Y, Jin Z, Feng H, Wang Y, Wen C, Qian H, Zhao R,, Shen B, Peng C.
|
Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy.
|
Oncotarget
|
2017
|
8(29):47841-47848
|
|
Ma D, Shen B, Seewoo V, Tong H, Yang W, Cheng X, Jin z, Peng C,
|
The Role of GADD45β Induction by S-adenosylmethionine in Hepatocellular Carcinoma Inhibition during Acute Ischemia-Hypoxia.
|
Oncotarget
|
2016
|
7(24):37215-37225
|
|
Li K, Shen B, Cheng X, Ma D, Jing X, Liu X, Yang W, Peng C,
|
The Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript of Fibroblast Growth Factor Receptor 3 in Hepatocellular Carcinoma.
|
Cancer Research
|
2016
|
76(14):1-10
|
|
Ma D, Jing X, Shen B, Liu X, Cheng X, Wang B, Fu Z, Peng C,
|
Leukemia Inhibitory Factor Receptor Negatively Regulates Metastasis of Pancreatic Cancer Cells in vitro and in vivo.
|
Oncology Reports,
|
2016
|
36(2): 827-836
|
|
Liu X, Jing X, Cheng X, Ma D, Jin Z, Yang W,
|
FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.
|
Medical Oncology
|
2016
|
33(5):46-57
|
|
Cheng X, Wang B, Jin Z, Ma D, Zhao R, Shen B, Peng C,
|
Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling
|
Oncotarget
|
2016
|
7(47):77916-77925
|
|
Liu X, Ma D, Jing X, Wang B, Yang W,
|
Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis
|
Med Oncol
|
2015
|
32(1):392
|
|
程兮, 杨卫平, 罗茜, 马丁, 汪炳瑞, 沈柏用, 彭承宏,
|
螺旋型鼻肠管在胃癌根治术加速康复中的临床价值
|
中华消化外科杂志
|
2015
|
14(1):61-65
|
|
程兮,
|
肝癌合并门静脉癌栓的多学科治疗进展
|
外科理论与实践
|
2015
|
20(4):360-363
|
|
林大伟、马丁、杨卫平、沈柏用、彭承宏,邱伟华
|
胰腺癌增生分化及凋亡相关蛋白互作动态网络特征分析
|
中华实验外科杂志
|
2015
|
32(11), 2642-2645
|
|
汪炳瑞, 程兮, 杨卫平, 景晓乾, 马丁, 刘心玉, 沈柏用, 彭承宏,
|
铜绿假单胞菌对胰腺癌细胞的抑癌效应及分子机制研究
|
外科理论与实践
|
2015
|
20(4):327-332
|
|
程兮, 杨卫平, 马丁, 刘心玉, 汪炳瑞, 沈柏用, 彭承宏,
|
S 腺苷甲硫氨酸对肝细胞癌手术病人的疗效
|
外科理论与实践
|
2015
|
20(5):403-407
|
|
马丁, 林大伟, 杨卫平, 程兮, 汪炳瑞, 沈柏用, 彭承宏,
|
以 EP300 为中心的胰腺癌相关蛋白质相互作用网络特征分析
|
外科理论与实践
|
2015
|
20(5):429-433
|
|
汪炳瑞,
|
胰腺癌嗜神经侵袭的解剖和分子生物学研究进展
|
中华肝胆外科杂志
|
2014
|
20(4):314-317
|
|
李科, 杨卫平, 付志平, 汪炳瑞, 景晓乾, 沈柏用, 彭承宏,
|
ShRNA 靶向沉默 FGFR3 基因对人肝癌细胞 Huh7 增殖和迁移的影响
|
外科理论与实践
|
2014
|
19(4):342-348
|
|
林大伟,
|
生物信息学在胰腺癌中的应用
|
国际消化病杂志
|
2014
|
34(1):44-47
|
|
杨卫平, 朱纯超, 景晓乾, 汪炳瑞, 沈柏用, 彭承宏,
|
人工肝血浆置换治疗对肝功能衰竭患者移植相关免疫功能的影响
|
中华实验外科杂志
|
2014
|
31(7):1559-1562
|
|
付志平, 杨卫平, 李科, 景晓乾, 汪炳瑞, 沈柏用, 彭承宏,
|
自噬在吉西他滨诱导胰腺癌细胞凋亡中的作用
|
外科理论与实践
|
2014
|
19(4):329-334
|
|
王佳玉、杨卫平、邱伟华
|
II型程序性细胞（自噬）在肿瘤中作用的研究进展
|
外科理论与实践
|
2013
|
18(4), pp 384-386
|
|
葛覃, 房嫣, 杨卫平, 付志平, 李科, 佟辉, 施敏敏,
|
3 - 氨基吡啶 - 2 - 甲醛硫代缩氨基脲对不同 p53 状态肝癌细胞中生长抑制及 DNA 损伤诱导基因 45β的诱导差异及其机制
|
中华实验外科杂志
|
2013
|
30(10):2029-2031
|
|
佟辉、杨卫平、林大伟、施敏敏、沈柏用、彭承宏、李宏为、邱伟华
|
腺苷甲硫氨酸对肝癌细胞急性缺血/缺氧过程中 的生物学作用
|
外科理论与实践
|
2013
|
18(5), pp 435-439
|
|
, 任家俊, 温晨磊, 彭承宏
|
精准肝切除治疗肝尾状叶巨大肿瘤
|
中华消化外科杂志
|
2013
|
12(11):855-858
|
|
佟辉, 杨卫平,
|
自噬在肿瘤治疗中的研究进展
|
中华肝胆外科杂志
|
2013
|
18(11):886-888
|
|
佟辉, 杨卫平,
|
细胞自噬在肝脏疾病中的研究进展
|
中华实验外科杂志
|
2013
|
29(10):2097-2098
|
|
瓦伦、佟辉、杨卫平、邱伟华
|
生长抑制及DNA损伤诱导基因45在肝细胞性肝癌中的意义
|
中华实验外科杂志
|
2013
|
30(1):187-188
|
|
佟辉, 杨卫平, 林大伟, 施敏敏, 沈柏用, 彭承宏, 季宏为,
|
S 腺苷蛋氨酸与氯喹联合应用对肝癌细胞急性缺血 / 缺氧过程中生物学特性的影响
|
中华肝胆外科杂志
|
2013
|
19(11):846-851
|
|
王佳玉,杨卫平,林大伟,瓦伦,李军,施敏敏,沈柏用,彭承宏,
|
奥沙利铂对不同p53状态肝癌细胞中GADD45β的诱导差异及调控机制
|
中华肝胆外科杂志
|
2012
|
18(2):130-134
|
|
Du H, Chen L, Yang W, Chen H, Shi M, Zhang R,
|
Involvement of reactive oxygen species in Sorafernib-induced autophagy in HepG2 cells
|
Asian J Chem
|
2012
|
24(6) :2617-2621
|
|
Du H, Yang W, Chen L, Shi M, Seewoo V, Wang J, Lin A, Liu Z,
|
Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells
|
Oncol Rep
|
2012
|
27(1):143-150
|
|
Seewoo V, Yang W, Du H, Wang J, Lin A, Shen B, Peng C, Li H,
|
The Different Induction Model of Growth Arrest DNA Damage-Inducible Gene 45 β in Human Hepatoma Cell Lines
|
Chemotherapy
|
2012
|
58(2):165-74
|
|
杜海磊,佟 辉,陈 聆,施敏敏,刘卓然,李 军,匡 洁,杨卫平,
|
急性缺血/缺氧诱导肝癌细胞自噬及其相关机制
|
外科理论与实践
|
2012
|
17(6):649-653
|
|
Seewoo V, Jin X, Yang W, Wang J, Chu PG, Yen C,
|
Increased Mortality from Delayed Diagnosis and Treatment of Obturator Hernia in Elderly Patients.
|
Am Sur
|
2012
|
78(4):229-231
|
|
Du H, Yang W, Chen L, Shen B, Peng C, Li H, Ann DK, Yen Y,
|
Increased Mortality from Emerging role of autophagy during ischemia-hypoxia and reperfusion in hepatocellular carcinoma.
|
Int J Oncol.
|
2012
|
40(6):2049-57
|
|
王佳玉,杨卫平,林大伟,衣琳,李军,汪洋,覃胜灵,施敏敏,沈柏用,彭承宏,
|
Triapine对肝癌细胞株HepG2中GADD45B表达影响及其可能机制
|
外科理论与实践
|
2011
|
16(5):481-487
|
|
王佳玉,杨卫平,林大伟,衣琳,施敏敏,
|
羟基脲对不同p53状态肝癌细胞中GADD45B的诱导差异及调控机制
|
中华实验外科杂志
|
2011
|
28(10):1632-1635
|
|
衣琳,金筱泰,瓦伦,王佳玉,杨卫平,丁家增,
|
闭孔疝的临床诊断与治疗
|
外科理论与实践
|
2011
|
16(2):185-187
|
|
衣琳,,马韬
|
胰腺癌辅助治疗的若干热点问题
|
外科理论与实践
|
2011
|
16(3):319-322
|
|
衣琳,金筱泰,姚永良,瓦伦,王佳玉,杨卫平,丁家增,
|
胆囊穿孔和严重肝硬化致支气管胆管瘘
|
外科理论与实践
|
2011
|
16(4):405-407
|
|
杜海磊,杨卫平,陈聆,施敏敏,汪洋,李军,刘卓然,陈拥军,严佶祺,匡洁,李勤裕,Seewoo Varun,
|
索拉菲尼抑制肝癌细胞增殖中自噬的作用及其价值
|
外科理论与实践
|
2011
|
16(3):105-109
|
|
孙广涛,陈皓,
|
自噬在肝癌中的表达及相关机制研究进展
|
中华实验外科杂志
|
2010
|
27:(4):100-102
|
|
杜海磊,,杨卫平
|
细胞自噬与肿瘤
|
中国病理生理杂志
|
2010
|
26(2):401-404
|
|
,Bingsen Zhou ,Peiguo G. Chu,
|
羟基脲对肝癌细胞HepG2中GADD45β表达影响及其可能机制
|
中华肝胆外科杂志
|
2010
|
16(4):290-294
|
|
杜海磊 杨卫平 陈聆 施敏敏 陈皓 严佶祺 李勤裕 匡洁 邱伟华
|
自噬的特异性抑制对肝癌细胞凋亡的调控及其相关机制
|
外科理论与实践
|
2010
|
15(6):117-121
|
|
Shao T, Yang W, Zhang T, Wang Y, Jin X, Li Q, Kuang J,, Chu PG, Yen Y
|
A newly identified variation at the entry of the recurrent laryngeal nerve into the larynx
|
J Invest Surg
|
2010
|
23(6):314-320
|
|
杨卫平,覃胜灵,姚永良,衣琳,施敏敏,陈皓,
|
p53对肝癌细胞中GADD45β表达诱导的影响及其调控机制
|
中华实验外科杂志
|
2010
|
27(2):156-160
|
|
张贵阳, 杨卫平, 陈皓, 施敏, 孙广涛, 杜海磊,
|
FGFR3在大鼠肝硬化模型中的动态表达研究
|
外科理论与实践
|
2009
|
14(6):627-632
|
|
Yang W, Ding J, Jin X, Wu H, Kuang J, Tao Z, Chu P G. Yen Y, Qiu W
|
The Plication and Splinting Procedure for Idiopathic Sclerosing Encapsulating Peritonitis.
|
J Invest Surg
|
2009
|
22(4):286-291
|
|
卢业才,李启信,束庆兵,郭峰,王光庆,孙功平,朱长进,
|
丹参酮ⅡA磺酸钠联合顺铂腹腔化疗对胃癌生长的影响
|
肿瘤基础与临床
|
2009
|
22(02):121-124
|
|
Yang W, Tao Z, Chen H, Li Q, Chu P G, Yen Y,
|
Amyand's Hernia in elderly patients: diagnostic, anesthetic, and perioperative considerations.
|
J Invest Surg
|
2009
|
22(6):426-429
|
|
覃胜林,陈皓,
|
Toll样受体在肿瘤中的研究进展
|
中华实验外科杂志
|
2009
|
26(9):1233-1234
|
|
姚永良,杨卫平,
|
门静脉高压外科治疗现状和展望
|
中国现代普通外科进展
|
2009
|
12(3):24-237
|
|
Yang W, Shao T, Ding J, Jin X, Li Q, Chu P G, Yen Y,
|
The feasibility of total or near-total bilateral thyroidectomy for the treatment of bilateral multinodular goiter.
|
J Invest Surg
|
2009
|
22(3):195-200
|
|
Xue L, Lu Y,, Zhou H, Zhang G, Jin Z, Lin M, Chen H, Rui Z, Zheng Y
|
Surgical experience of refined 3-cuff technique for orthotopic small-bowel transplantation in rat: a report of 270 cases
|
Am J Surg
|
2009
|
198:110-121
|
|
,BingsenZhou,陈皓
|
S腺苷甲硫氨酸对肝癌细胞中GADD45β基因的表达诱导及其机制研究.
|
中华肝胆外科杂志
|
2008
|
14(12):872-876
|
|
, Zhou B, Chu PG, Luh F, Yun Yen.
|
The Induction of Growth Arrest DNA Damage-Inducible Gene 45 β in Human Hepatoma Cell Lines by S-adenosylmethionine.
|
Am J Pathol
|
2007
|
171(1):287-296
|
|
,陈皓,沈柏用
|
siRNA对肝癌细胞中特异性异常表达FGFR3基因的抑制效应研究
|
中华肝胆外科杂志
|
2007
|
13(10):686-689
|
|
,Bingsen Zhou,Dana Darwish
|
STAT3在SAMe抑制HepG2细胞VEGF表达中的作用
|
上海交通大学学报（医学版）
|
2006
|
26(6):576-580
|
|
, Zhou B, Darwish D, Shao J, Yen Y
|
Characterization of Enzymatic Properties of Human Ribonucleotide Reductase Holoenzyme Reconstituted in vitro from hRRM1, hRRM2, and p53R2 SubunitsOxaliplatin
|
Biochem Biophys Res Commun
|
2006
|
340(2):428-434
|
|
, Bingsen Zhou, Dana Darwish
|
GADD45β基因表达诱导对不同p53状态的肝癌细胞作用及可能机制
|
外科理论与实践
|
2005
|
10(2):165
|
|
, Zhou B, Chu PG, Liu X, Chen W, Chung C, Hwu P, Yeh C, Lopez R, Yen Y
|
Over-expression of Fibroblast Growth Factor Receptor 3 in Human Hepatocellular Carcinoma
|
World J Gastroenterol.
|
2005
|
11(34):5266-5272
|
|
Qian S, Somlo G, Zhou B, Zhu L, Mi S, Mo X, Cheung EM,, Lin RJ, Rossi J, Holtz M, Chu P, Yen Y
|
Ribozyme cleavage leads to decreased expression of fibroblast growth factor receptor 3 in human multiple myeloma cells, which is associated with apoptosis and downregulation of vascular endothelial growth factor
|
Oligonucleotides
|
2005
|
15(1):1-11
|
|
, Zhou B, Zou H, Chu PG, Lopez Richard, Shih Jennifer, Chung Christopher, Yen Y
|
Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 β Promoter in Human Hepatocellular Carcinoma
|
Am J Pathol.
|
2004
|
165(5):1689-1699
|
|
, Zhou B, Zou H, Chu PG, Lopez Richard, Shih Jennifer, Chung Christopher, Yen Y
|
Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 β Promoter in Human Hepatocellular Carcinoma
|
Am J Pathol
|
2004
|
165:1689-1699
|
|
Shao J, Zhou B, Zhu L,, Yuan YC, Xi B, Yen Y
|
In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductase
|
Cancer Res
|
2004
|
64(1):1-6
|
|
Liu X, Zhou B, Xue L,, Shih J, Zheng S, Yen Y
|
Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone
|
Biochem Pharmacol
|
2004
|
67(8):1499-511
|
|
, David D, Zhou B, Chu PG, Zhang B, Wu M, Xiao J, Han T, Zhu Z, Wang T, Liu X, Lopez R, Frankel P, Jong A, Yen Y
|
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma
|
Am J Pathol
|
2003
|
162(6):1961-1974
|
|
, David D, Zhou B, Chu PG, Zhang B, Wu M, Xiao J, Han T, Zhu Z, Wang T, Liu X, Lopez R, Frankel P, Jong A, Yen Y
|
Hypermethylation of Growth Arrest DNA Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
|
Am J Pathol.
|
2003
|
162(6):1961-7
|
|
Xue L, Zhou B, Liu X,, Jin Z, Yen Y
|
Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits
|
Cancer Res
|
2003
|
63(5):980-986
|
|
Zhou B, Liu X, Mo X, Xue L, Darwish D,, Shih J, Hwu EB, Luh F, Yen Y
|
The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53
|
Cancer Res
|
2003
|
63(20):6583-6594
|
|
Zhou B, Mo X, Liu X,, Yen Y
|
Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance
|
Cytogenet Cell Genet
|
2001
|
95(1-2):34-42
|
|